| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.003 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.14 | 0.005 |